Issue 5/2017
Content (9 Articles)
Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glargine 300 U/mL
Jennifer N. Clements, Tiffaney Threatt, Eileen Ward, Kayce M. Shealy
Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat
Bishoy Kamel, Garry G. Graham, Kenneth M. Williams, Kevin D. Pile, Richard O. Day
Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib
Steven A. Lacy, Dale R. Miles, Linh T. Nguyen
Pharmacokinetics and Pharmacodynamics of Lurasidone Hydrochloride, a Second-Generation Antipsychotic: A Systematic Review of the Published Literature
William M. Greenberg, Leslie Citrome
Population Pharmacokinetics of Necitumumab in Cancer Patients
Amanda Long, Emmanuel Chigutsa, Johan Wallin
Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
Kevin J. Freise, Aksana K. Jones, Doerthe Eckert, Sven Mensing, Shekman L. Wong, Rod A. Humerickhouse, Walid M. Awni, Ahmed Hamed Salem
Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine
Bruce Green, Herta Crauwels, Thomas N. Kakuda, Simon Vanveggel, Anne Brochot
A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways
Maïlys De Sousa Mendes, Gabrielle Lui, Yi Zheng, Claire Pressiat, Deborah Hirt, Elodie Valade, Naïm Bouazza, Frantz Foissac, Stephane Blanche, Jean-Marc Treluyer, Saik Urien, Sihem Benaboud
A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes
Tim Heise, Thomas R. Pieber, Thomas Danne, Lars Erichsen, Hanne Haahr